ERBB2 and cancer: The most studied biomarkers and cancer entities, presented in Figure 12, were: carcinoembryonic antigen (16.8%), MCF-7 cells (13%), exosomes (12.2%), mucin 1 (10.7%), and human epidermal growth factor receptor 2 (7.6%) (RQ6).